Octahydrocondensed azadecalin glucocorticoid receptor regulator
JP2026094404APending Publication Date: 2026-06-09CORCEPT THERAPEUTICS INC
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- CORCEPT THERAPEUTICS INC
- Filing Date
- 2026-03-10
- Publication Date
- 2026-06-09
Smart Images

Figure 2026094404000001_ABST
Abstract
To provide novel compositions and methods for modulating GR receptors. [Solution] The present invention provides an octahydrocondensed azadecalin compound and a method for using the compound as a glucocorticoid receptor modulator. In some embodiments, the present invention provides a pharmaceutical composition comprising the compound of the present invention and a pharmaceutically acceptable excipient. In some embodiments, the present invention provides a method for modulating a glucocorticoid receptor, the method comprising the step of contacting the glucocorticoid receptor with the compound of the present invention, thereby modulating the glucocorticoid receptor.
Need to check novelty before this filing date? Find Prior Art
Claims
[Claim 1] The need for a method for modulating GR receptors.